Log in to save to my catalogue

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-res...

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-res...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9de32145158d49b7a57f887cc6bef5b4

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy

About this item

Full title

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2022-04, Vol.20 (1), p.206-206, Article 206

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by diffuse inflammation of the colonic mucosa and a relapsing and remitting course. The current therapeutics are only modestly effective and carry risks for unacceptable adverse events, and thus more effective approaches to treat UC is clinically needed.
For this purpos...

Alternative Titles

Full title

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9de32145158d49b7a57f887cc6bef5b4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9de32145158d49b7a57f887cc6bef5b4

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-022-01421-w

How to access this item